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Intrinsically disordered proteins (IDPs) are ubiquitous in eukaryotes, and
they are often associated with diseases in humans. The protein
NUPR1 is a multifunctional IDP involved in chromatin remodeling and
in the development and progression of pancreatic cancer; however, the
details of such functions are unknown. Polycomb proteins are involved
in specific transcriptional cascades and gene silencing. One of the
proteins of the Polycomb complex is the Ring finger protein 1 (RING1).
RING1 is related to aggressive tumor features in multiple cancer types.
In this work we characterized the interaction between NUPR1 and the
paralogue RING1B in vitro, in silico, and in cellulo. The interaction
occurred through the C-terminal region of RING1B (C-RING1B), with an
affinity in the low micromolar range (∼10 μM). The binding region of
NUPR1, mapped by NMR, was a hydrophobic polypeptide patch at the
30s region of its sequence, as pinpointed by computational results and
site-directed mutagenesis at Ala33. The association between C-RING1B
and wild-type NUPR1 also occurred in cellulo as tested by protein liga-
tion assays; this interaction is inhibited by trifluoperazine, a drug
known to hamper binding of wild-type NUPR1 with other proteins.
Furthermore, the Thr68Gln and Ala33Gln/Thr68Gln mutants had a re-
duction in the binding toward C-RING1B as shown by in vitro, in silico,
and in cellulo studies. This is an example of a well-folded partner of
NUPR1, because its other interacting proteins are also unfolded. We
hypothesize that NUPR1 plays an active role in chromatin remodeling
and carcinogenesis, together with Polycomb proteins.
IDP | NUPR1 | Polycomb group | RING1B
Gene expression control occurs through the combined activ-ities of transcription factors and chromatin regulators, con-
sidered as effectors of epigenetic mechanisms. Posttranslational
modifications of nucleosomal histones, DNA methylation, local
compaction, and long-range interactions determine a variety of
chromatin structures that can affect the transcriptional output.
A group of chromatin regulators are the Polycomb Repressive
complexes (PRCs) (1, 2). These Polycomb group (PcG) proteins are
encoded by genes initially discovered over 60 years ago as repressors
of the Hox genes inDrosophila (3). The PcG proteins form two main
silencing heteromeric complexes called PRC1 and PRC2; both are
highly conserved in eukaryotes and either in isolation or synergisti-
cally can silence genes (4, 5). The catalytic functions of both com-
plexes include ubiquitin-ligase (H3K119ub1) and methyltransferase
activity (H3K27Me3), respectively. In mammals, the PRC2 core is
formed by, at least, four heteromeric units, one of which is EZH2 (or
its paralog, EZH1), the methyltransferase that catalyzes the trime-
thylation of histone H3 at Lys27 (5). This modification can act as an
anchoring site of PRC1 complexes containing chromobox (CBX)
proteins. These CBX proteins recruit PRC1 complex onto PRC2-
enriched chromatin, facilitating the monoubiquitylation. The PRC1-
dependent monoubiquitylation at Lys119 of histone H2A correlates
with transcriptional repression (6–9). This process is carried out by a
heterodimeric RING finger E3 ligase, whose subunit binding the
E2 ligase is RING1B, or its paralog RING1A. The other member
of the heterodimer is one out of a group of six Polycomb Ring
finger proteins (whose best-known member is perhaps BMI1),
thought to act as a positive cofactor (10, 11). It has been shown
that RING1B is involved in several human cancers (12–15), es-
pecially in human hepatocellular carcinomas and pancreatic can-
cer (16). However, its exact function during the development of
such cancers is yet unknown.
We have described the conformational properties of the
C-terminal domain of RING1B (C-RING1B), encompassing the
residues 227–334 (17), and shown that it is a dimer of well-formed
monomers. The X-ray structure of the monomers of C-RING1B
resembles that of a ubiquitin module, and it serves to interact
with CBX proteins (18). Furthermore, we have also shown that
C-RING1B is capable of interacting with RING1 and YY1 binding
protein (RYBP) (19, 20), which is a highly basic, oligomeric, in-
trinsically disordered protein (IDP) that interacts with DNA (19)
and other proteins involved in apoptosis (21–23). The CBX proteins
binding to C-RING1B undergo a tightening in their structures (24),
and their presence hampers RYBP binding (25). Taken together,
these results suggest that C-RING1B could be involved in binding to
different partners, acting as a modulator of several protein cascades.
NUPR1 is an 82-residue-long (8-kDa), highly basic, monomeric
IDP that is overexpressed during the acute phase of pancreatitis
(26). As happens with many IDPs (27–29), NUPR1 does not have
stable secondary and tertiary structure in any region of its sequence.
Similarly to other chromatin proteins, NUPR1 binds to DNA (30);
it can be regulated by cell signaling cascades to transduce gene
regulatory, morphogenetic signals from cell membrane to the
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nucleus. Although NUPR1 is considered to function as a scaffold
protein in transcription, and as an essential element for the stress
cell response and in cell-cycle regulation, the distinct function me-
diated by this protein is currently debated (31, 32). Indeed,
NUPR1 participates in the regulation of apoptosis by forming a
complex with another IDP, prothymosin α (33), as well as being
involved in DNA repair (34). In addition, NUPR1 plays key roles
in pancreatic tumorigenesis, acting downstream of the KrasG12D
oncogenes, which are critical for pancreatic carcinogenesis (35).
Therefore, given the similarities in the physicochemical properties
of RYBP and NUPR1 (namely, high isoelectric point, DNA-
binding features, and an intrinsic disordered state), and the in-
volvement of C-RING1B in some types of cancer, we hypothesize
that this domain might also bind to NUPR1.
To test this hypothesis we carried out the in vitro characterization
of the binding between both proteins by using spectroscopic (namely,
fluorescence, NMR, and CD) and biochemical (proteolysis degra-
dation) techniques. Furthermore, in cellulo assays were carried out
by means of the protein ligation assay (PLA) and NUPR1 knock-out
cells by CRISPR/Cas9n-mediated genome editing to assess the in-
teraction specificity. Our hypothesis-driven experiments show that
there was binding between these proteins both in cellulo and in vitro,
with an affinity of ∼10 μM. The binding region of NUPR1 involves a
hydrophobic patch at the 30s region of the protein, but the protein
remained disordered upon binding. Blind in silico studies carried out
by using the X-ray structure (18) of C-RING1B in interaction with all
possible polypeptide patches of NUPR1 show that the binding region
involves Ala33 of NUPR1 and its hydrophobic surroundings, as well
as another hydrophobic patch around Thr68. We also tested the
importance of these regions in binding to C-RING1B by generating
the single, Thr68Gln, and the double, Ala33Gln/Thr68Gln, mutants
(the single mutant Ala33Gln could not be expressed in Escherichia
coli). Although the interaction with C-RING1B was not fully abol-
ished in vitro, both the single and double mutants had larger disso-
ciation constants (i.e., less affinity toward C-RING1B) than wild-type
NUPR1, as measured by fluorescence and NMR. Thus, both posi-
tions (Ala33 and Thr68) are important for the binding of NUPR1 to
C-RING1B, and Ala33 seems to be particularly critical to achieve
local hydrophobic clustering. PLA was also performed in cellulo with
the three NUPR1 mutants, and the results showed a complete dis-
appearance of the interaction with C-RING1B. Interestingly enough,
in contrast to the previously characterized and identified protein
partners of NUPR1 [prothymosin α and male-specific lethal (MSL)
proteins], C-RING1B is a well-folded protein. Our findings suggest
that NUPR1 may play a C-RING1B–associated function within the
Polycomb pathway, which may help to explain both its gene regu-
latory and oncogenic functions.
Results
C-RING1B and NUPR1 Interact in Vitro. To test whether C-RING1B
and NUPR1 interacted in vitro we followed a four-part approach.
First, we tried isothermal titration calorimetry (ITC) experiments
at several pH values above 7.0 between wild-type NUPR1 and
C-RING1B; in all conditions explored we did not observe a binding-
associated heat signal. Because we observed binding by using other
techniques (discussed below), the absence of thermogram in ITC
could be due to (i) a low affinity due to a high flexibility in the
complex (36, 37) or (ii) a very small amount of heat exchange with
the environment. Based on our results (discussed below), we suggest
that the most plausible explanation is the latter.
Second, we used fluorescence spectroscopy to determine whether
there was either a change in the maximum wavelength or in the
intensity when the spectrum of the complex was compared with that
obtained from the addition of each one of the isolated proteins. A
variation in fluorescence intensity was observed when the complex
formed (Fig. 1A, Inset), but there were no changes in the maximum
wavelength of the spectrum. We can conclude that the two proteins
bind, and binding alters mainly the environment of the sole
tryptophan of C-RING1B. Therefore, we used fluorescence to de-
termine the affinity constant (Fig. 1A), leading to a Kd of 6 ± 2 μM,
which results in a free energy of binding of −7.1 ± 0.3 kcal/mol.
We also measured the binding of both mutants, Thr68Gln and
Ala33Gln/Thr68Gln, to C-RING1B. Both mutants were designed
to hamper the interaction based on our previous in silico results of
the whole intact NUPR1 (38). The titration curves were always
noisier than those of wild type (Fig. S1), yielding Kds of 9 ± 2 μM
and 14 ± 5 μM for Thr68Gln and Ala33Gln/Thr68Gln, respectively,
which are slightly larger than that measured in the wild type. These
results suggest that the affinity of both mutants is not as large as that
of the wild-type protein in vitro.
In the third step of our approach we carried out far-UV CD
experiments. As in fluorescence, the addition spectrum (obtained
from the sum of the isolated spectra of both proteins) for the
Fig. 1. Spectroscopic characterization of the binding between C-RING1B
and wild-type NUPR1. (A) Changes in the intensity at 330 nm with in-
creasing amounts of wild-type NUPR1 after excitation at 295 nm. The line
through the data is the fitting to Eq. 1, yielding a Kd of 6 ± 2 μM. (Inset)
Fluorescence spectra of the complex between wild-type NUPR1 and
C-RING1B (continuous black line) and that obtained by the addition of the
spectra of each protein (dotted red line). (B) Thermal denaturations followed
by the changes in ellipticity at 222 nm of the complex of the two proteins
and that of isolated C-RING1B. (Inset) Far-UV CD spectra of the complex
(continuous black line) and that obtained by the addition of the spectra of
each protein (dotted red line). a.u., arbitrary units; mdeg, millidegrees.
Santofimia-Castaño et al. PNAS | Published online July 18, 2017 | E6333
BI
O
PH
YS
IC
S
A
N
D
CO
M
PU
TA
TI
O
N
A
L
BI
O
LO
G
Y
PN
A
S
PL
U
S
wild-type NUPR1 was different from that of the complex (Fig. 1B,
Inset). In both mutants there were differences between the addi-
tion spectrum of both C-RING1B and the corresponding mutant
and that of the matching complex, but the changes were not as
large as those of the wild-type protein (Fig. S2), suggesting a de-
creased affinity. Next, we carried out thermal denaturations of the
corresponding complex and isolated C-RING1B: The interaction
with wild-type or NUPR1 mutants should increase the thermal
stability of C-RING1B if the complex dissociates before the rate-
limiting step of denaturation. As expected, the presence of wild-
type NUPR1 increased the apparent thermal denaturation midpoint
(Fig. 1B). The presence of any of the mutants in solution with
C-RING1B did also increase, as much as with the wild-type
NUPR1, the apparent thermal midpoint for C-RING1B (Fig. S3).
We did not determine Kd from changes in the denaturation mid-
points due to the irreversibility of C-RING1B thermal denaturations
(17) (with all NUPR1 species we observed precipitation). Thus, we
conclude that we could detect binding by far-UV CD of wild-type
NUPR1 and C-RING1B, leading to changes in the secondary
structure of, at least, one of the proteins. We could also detect
binding of C-RING1B to NUPR1 mutants, but in both cases the
changes in the secondary structure were smaller compared with
those observed in the binding to wild-type NUPR1.
Finally, we tried to characterize the binding by means of
proteolysis degradation (39). In Fig. 2A we show representative
gels for the degradation of wild-type NUPR1 by thermolysin
either in the absence or in the presence of C-RING1B. Even with
a high proportion of acrylamide in the Tris-Tricine gels, some
overlap occurred between the two bands. However, it did not
preclude us from carrying out independent densitometric anal-
yses of the bands. In Fig. 2 B and C we show the protection
against degradation of wild-type NUPR1 by C-RING1B in a
concentration-dependent manner. The analyses, using a simple
model (SI Materials and Methods), are shown in Fig. 2D. The
slope of this plot is −0.9 ± 0.2, consistent with a 1:1 stoichiometry
(note that this slope should be equal to −1), and supports the
adequacy of the proposed model. The y axis intercept is 2.6 ± 1.1
[= ln(Kd) in micromolar], corresponding to a Kd = 12 ± 5 μM.
This value is similar, within the error, to that measured by
fluorescence and leads to a free energy of −6.6 ± 0.7 kcal/mol.
Thus, to sum up, the three techniques used show that C-RING1B
and wild-type NUPR1 interact in vitro with a low affinity constant
in the range of 10 μM. This interaction seems to be decreased in
the two NUPR1 mutants.
The C-RING1B Binding Maps to a Hydrophobic Region Located at the
30s of NUPR1 Sequence. To characterize the molecular bases be-
hind the formation of the C-RING1B/NUPR1 complex we
sought to determine the NUPR1 regions involved in binding.
Because we have previously reported the NMR assignment of
all residues of wild-type NUPR1 (34) (Biological Magnetic Reso-
nance Data Bank no. 19364), we used 1H-15N heteronuclear single
quantum correlation (HSQC) spectra of wild-type NUPR1 to
monitor changes upon C-RING1B addition.
We carried out the experiments at pH 7.0, where C-RING1B
was stable (17). At this pH, the most protected residues from
exchange of wild-type NUPR1 that could be unambiguously
assigned were (Fig. 3A) Gly16, Glu18, Asp19, Ser22 (Ser10),
Ser23 (Asn53), Ser27, Leu29, Tyr30, Ser31, and Arg82 (the resi-
dues within parentheses are those where signal overlapping oc-
curs). Most of these residues were close to the hydrophobic 30s
region (38) or, alternatively, they were partly sequestered from the
solvent by local structure or hydrogen bonding (40, 41). Upon
addition of C-RING1B, the cross-peaks began to disappear (Fig.
3A), and those whose signal intensities decreased faster were
Ser22 (Ser10), Ser23 (Asn53), Ser27, Leu29, Tyr30, and Ser31;
this decrease suggests a closer proximity to the Polycomb protein.
However, the residues whose cross-peak intensities were the
largest at the highest wild-type [NUPR1] were Gly16, Glu18, and
Asp19 (i.e., their cross-peak intensities decreased more slowly)
(Fig. 3B); this result suggests that these residues are less close to
C-RING1B. However, the decrease in intensities did not follow a
hyperbolic behavior for any of the residues (Fig. 3B). Moreover,
there was no variation in the chemical shifts of any of the residues,
and then, given the exquisite sensitivity of chemical shifts, it seems
that NUPR1 remained disordered upon binding. Furthermore,
because there were changes only in the intensities, the equilibrium
exchange between the free and bound wild-type NUPR1 must be
intermediate to slow within the NMR time scale. It is important to
note here that we observed larger intensity values for some
NUPR1 residues at larger C-RING1B concentrations [see, for
instance, Fig. 3A, residues Gly16, Glu18, and Leu29 at 0 and
64 μM (in protomer units) of C-RING1B, black and red bars,
respectively]. We think that those variations are due to error of the
measurements in the spectra, even though we corrected the
measured values by the figure obtained when setting the receiving
gain of the spectrometer. It is also well known that the measure-
ment of intensities in 2D HSQC NMR spectra is plagued with
several difficulties (42), and even the viscosity of the medium
(which is altered by the presence of other molecules) can affect
the value measured (43), even though at the total protein con-
centrations used in this work (∼500 μM) we have not observed
broadening in the spectra of isolated NUPR1 (34) or C-RING1B
(17). The facts that (i) broadening is only observed when titration
is carried out (i.e., when the corresponding protein partner is
added) and (ii) broadening of the signals of C-RING1B in the
HSQC spectra follows a different pattern when the mutants are
titrating (with molecular weight similar to that of the wild type,
discussed below) suggest that the binding between the two pro-
teins is mainly responsible for the broadening of signals. We also
observed a large change in the intensities of residues ongoing from
64 to 96 μM (in protomer units) of C-RING1B; the reasons for
this change are not fully understood, but they could be due to the
increase of the dimeric population of C-RING1B.
We also tested complex formation by using 15N-labeled
C-RING1B, to which increasing amounts of wild-type NUPR1
Fig. 2. Protection of wild-type NUPR1 toward degradation by thermolysin
in the presence of C-RING1B. (A) Representative gels of the degradation
kinetics of wild-type NUPR1 (10 μM) in the absence or presence of 45 μM (in
protomer units) of C-RING1B. C-RING1B was resistant to proteolysis under
our conditions (10 nM thermolysin). (B) Kinetics of degradation of wild-type
NUPR1 in the absence (black symbols) or in the presence of C-RING1B
[22.5 μM, red symbols; 45 μM, blue symbols, 90 μM, green symbols (all in-
dicated in protomer units)]. Data are shown as means, and errors are SDs as
obtained from three independent experiments. (C) First-order rate constants
for wild-type NUPR1 degradation at different C-RING1B concentrations.
(D) Plot based on a simple kinetic model to estimate the Kd value of the
interaction between NUPR1 and C-RING1B. MW, molecular weight.
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were added (Fig. 4A). As happened with the 1H-15N HSQC spectra
of wild-type NUPR1, the cross-peak intensities of the spectra of
C-RING1B decreased upon wild-type NUPR1 addition. We did not
observe changes in the chemical shifts of any cross-peak, suggesting
that (i) binding is intermediate to slow within the NMR time scale
and (ii) the structure of C-RING1B remained basically unaltered.
In this case, however, the intensities for all its cross-peaks decreased
at the same rate in a hyperbolic manner. Fitting of intensity de-
crease of the cross-peak appearing at 9.40 ppm in the spectrum
of C-RING1B to Eq. 1 led to a Kd of 31 ± 16 μM (Fig. 4B),
a slightly higher value than those measured by fluorescence and
proteolysis. As a control, we also added to a 15N-labeled C-RING1B
sample increasing amounts of unlabeled, intact RYBP (Fig. S4).
As with wild-type NUPR1, we also observed a decrease of
cross-peak intensity as [RYBP] was raised.
We also tried to determine the binding affinity toward
C-RING1B of the Thr68Gln and Ala33Gln/Thr68Gln mutants
by means of HSQC NMR spectra of 15N-labeled C-RING1B. As
it happens with fluorescence, the affinity of the mutants was
substantially decreased compared with that of the wild-type
NUPR1, with values (Kds) of 65 ± 15 μM and 115 ± 85 μM
for the single and double mutants, respectively (Fig. S5). Thus,
all of the techniques suggest that the interaction with C-RING1B
is decreased by the two mutations, and it is lower in the double
mutant. Our results with the mutants also pinpoint the 30s region
of NUPR1 as a key polypeptide patch to attain binding.
In conclusion, the NMR experiments further confirm that
there is binding between the two proteins, involving residues
around the 30s region of NUPR1 sequence.
In Silico Calculations Show That the NUPR1 Patch Involved in the Binding Is
Also the 30s Region. Fig. 5 shows docking poses obtained for repre-
sentative portions of the wild-type NUPR1 sequence in our molec-
ular docking calculations. The NUPR1 region around Ala33 shows
the most favorable docking scores, with predicted binding energies up
to –7.8 kcal/mol for the capped seven-residue fragment. This value is
similar to the free energy experimentally obtained by fluorescence
and proteolysis. The interaction sites of this fragment with C-RING1B,
as well as those obtained with other shorter (five-residue and
three-residue) fragments centered on Ala33, were observed to group
in five well-defined locations, hereafter named clusters Cl-1 to Cl-5
(Fig. 5A). All these polypeptide patches comprise highly hydro-
phobic regions in C-RING1B, according to the Kyte–Doolittle
hydropathy scale (44) (Fig. S6). Cluster Cl-1 is in between the two
C-RING1B regions 226–227 and 307–312, both clusters Cl-2 and
Cl-3 involve the region 262–268, cluster Cl-4 Ring1B comprises the
polypeptide patch 295–296, and, finally, cluster Cl-5 is close to
amino acids 307–312.
Both the binding affinity and the number of recurring loca-
tions, identified through the molecular docking procedure, de-
creased for protein fragments centered on other residues along
the NUPR1 sequence. The region around the other key amino
Fig. 3. Interaction of wild-type NUPR1 and C-RING1B mapped by HSQC
spectra of NUPR1. (A) Overlay of wild-type NUPR1 spectra in the presence of
different amounts of C-RING1B: 0 (black), 64 (red), 96 (blue), and 110 (green)
μM (all indicated in protomer units). (B) Intensity decrease of cross-peaks
(corrected by the value of the receiver gain of the spectrometer in each ti-
trating point) in the 1H-15N HSQC spectra of wild-type NUPR1 as [C-RING1B]
was increased (color code is the same as above). The signals appearing be-
tween 8.15 and 8.30 (1H dimension) and between 123 and 121 ppm (the 15N
one) could not be unambiguously assigned. a.u., arbitrary units.
Fig. 4. Interaction of wild-type NUPR1 and C-RING1B mapped by HSQC
spectra of C-RING1B. (A) Overlay of C-RING1B selected spectra in the pres-
ence of different amounts of NUPR1: 0 (black), 20 (red), and 61 (blue) μM.
(B) Fitting of the absolute intensity (corrected by the value of the receiver gain
of the spectrometer in each titrating point) of the cross-peak of C-RING1B,
appearing at 9.40 ppm to Eq. 1; the Kd was 31 ± 16 μM. a.u., arbitrary units.
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acid Thr68, which together with Ala33 constitutes the most hy-
drophobic regions of its sequence (38) and is another anchoring
site to NUPR1 molecular partners, showed docking scores of
about –6.0 kcal/mol. However, Thr68 has a slightly higher pref-
erence for binding to cluster Cl-1 of C-RING1B (Fig. 5B),
compared with the preferred locations for Ala33. The number of
clusters reduced to two (Cl-1 and Cl-2) for the most hydrophilic
segments of the NUPR1 sequence, such as the highly charged
basic regions around Lys47 and Lys76 (Fig. 5 C and D). More-
over, it reduced to only Cl-1 for the highly acidic region centered
on Asp19 (Fig. 5E), which includes all of the residues whose
cross-peak intensities decreased more slowly in our NMR
experiments. Thus, the two clusters Cl-1 and Cl-2 represent
C-RING1B–interacting regions with low specificity, which could
assist the binding preferably through electrostatic interactions.
Our simulations reveal additional details about residues of
C-RING1B involved in the binding of NUPR1, which were ob-
scured in our experiments in vitro. In fact, NUPR1 binds close to
Leu311 and Glu312 in Cl-1, and it interacts with most of the
residues 262–268 region in Cl-2, and preferentially with residues
Tyr262 and Val265 in Cl-3. In the cluster Cl-4, both residues
Ala33 and Thr68 of NUPR1 bind to region 295–296 of C-RING1B,
with some of their adjacent amino acids interacting more closely
with the nearby region 307–312. Finally, Ala33 and Thr68, in Cl-5,
interact with the region 307–312, and in particular with residues
Gly307 and Ser308.
Although the two regions around Ala33 and Thr68 have in
common the possibility of anchoring to several C-RING1B
polypeptide patches, they also show some differences in their
respective binding features. In fact, the affinity obtained for the
seven-residue fragment centered on Ala33 decreased by up to
2 kcal/mol, when the length of the sequence portion was reduced
to five or three residues. Conversely, the predicted binding en-
ergy for the region around Thr68 was not length-dependent on
the NUPR1 fragment considered. These features may be
explained in terms of a high specificity in the interaction of the
side chain of Thr68 with the surface of C-RING1B within the
clusters. In contrast, for Ala33 the binding was due to less-
localized interactions that depended on a larger portion of the
NUPR1 sequence, and it also included significant contributions
by other adjacent protein residues.
We also carried out docking simulations of NUPR1 fragments
including both Ala33Gln and Thr68Gln mutations. Both were ob-
served to significantly alter the binding with C-RING1B, leading to
interaction energies less favorable by ∼2 kcal/mol and to a reduced
number of binding clusters (Fig. S7) compared with the wild-type
protein. In the case of the Thr68Gln mutant, the binding affinity of
the region around residue 68 toward C-RING1B becomes compa-
rable to that of highly hydrophilic NUPR1 regions, such as the
charged segments around Asp19, Lys47, and Lys76 (discussed
above). For the Ala33Gln mutant, the binding properties were
still not completely equivalent to the ones observed for the most
hydrophilic regions of NUPR1, although they seemed to be
drastically reduced.
Then, our in silico results suggest that NUPR1 and C-RING1B
interact through the same hydrophobic patch of the former pro-
tein mapped by NMR experiments, and that the mutations at
Ala33 and Thr68 decreased the binding toward C-RING1B to
a remarkable extent.
Evidence for the Interaction of RING1B with NUPR1 in an Intracellular
Environment. To test whether interaction between C-RING 1B and
wild-type NUPR1 occurred within cells we used HeLa cells
transfected with NUPR1-FLAG and RING1B-HA. Subsequently,
we sought to detect their interaction using the Duolink in situ
assay, which resolves the binding of proteins that occurs at dis-
tances less than 16 Å. Our results show that RING1B efficiently
interacted with wild-type NUPR1 (Fig. 6A), showing red fluores-
cent spots, corresponding to the PLA signals. We also showed the
specificity of wild-type NUPR1 for C-RING1B with the CRISPR/
Cas9n method, by simultaneously developing control and NUPR1
knockout cell lines (Fig. S8). In this experiment, only PLA-positive
signals were observed in control cells, and they were abolished in
NUPR1 knockout cells, demonstrating that the interaction be-
tween both proteins is specific.
We carried out experiments with expression of the proteins with
the FLAG label for both single (Ala33Gln and Thr68Gln) and
double (Ala33Gln/Thr68Gln) mutants. In all cases (Fig. S9) we
observed protein expression, but in wild-type NUPR1 transfected
cells the fluorescence signal appeared more concentrated in the
nucleus than when the NUPR1 mutants were used. That is, in the
mutants the signals appeared also in the cytoplasm of the cells, as if
a complete translocation of the protein was hampered. Finally, we
performed the PLAs to test the interaction between C-RING1B
and the three NUPR1 mutants in cellulo (Fig. S10). Under our
conditions no positive PLA signals were observed in NUPR1 single
mutants or in the double one, indicating that the two regions around
Ala33 and Thr68 are crucial for the interaction between C-RING1B
and NUPR1 also in an intracellular environment.
We have previously shown (38) that the interaction of wild-
type NUPR1 with MSL1 can be hampered by the addition of a
drug (trifluoperazine, TFP) competing for the same binding site
Fig. 5. Docking poses of selected portions of wild-type NUPR1 sequence to
C-RING1B. Fragments of NUPR1 are centered on (A) Ala33 and (B) Thr68.
Fragment length for wild-type NUPR1 is either seven (cyan), five (orange), or
three (purple) residues, with Cα atoms of the central amino acid represented as
spheres; clusters Cl-1 to Cl-5 are also labeled. Regions with high hydrophobicity
in C-RING1B are represented as transparent gray surfaces. The structures (C–E)
report docked structures of seven-residue fragments centered around Lys47,
Lys76, and Asp19, respectively. Figures were produced with VMD.
Fig. 6. In situ PLA of C-RING1B and wild-type NUPR1. (A) Mouse anti-HA
and rabbit anti-human wild-type NUPR1 were used to reveal the interaction
between the proteins in HeLa cells. (B) PLA was carried out as described (34);
cells were treated beforehand with TFP 50 μM for 24 h. ImageJ was used to count
the number of red dots. Data are the means of 10 fields each containing not
fewer than 150 nuclei counted (*P ≤ 0.001). (Magnification: A, 60×; B, 20×.)
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of the protein. Therefore, we wondered whether the interaction
between RING1B and wild-type NUPR1 could be also inhibited by
TFP. To this end, we incubated the HeLa transfected cells, as shown
above, with TFP at a concentration of 50 μM. In this case, the
positive red fluorescent signal in the cells was decreased, indicating
that TFP blocked the interaction of the two proteins (Fig. 6B).
Thus, taken together, these results demonstrate that a specific
C-RING1B/NUPR1 complex forms within cultured cells, where
residues Ala33 and Thr68 of NUPR1 seem to intervene in the
interacting region. These findings confirm the biological rele-
vance of our simulations and the biophysical and biochemical in
vitro experiments.
Discussion
An IDP Partner for PcG Proteins.NUPR1 is not the sole IDP capable
of interacting with C-RING1B, because also RYBP protein binds
to it (19, 20, 24, 25). The main physicochemical difference be-
tween RYBP and NUPR1 is that the former self-associates (both
are IDPs, DNA-binding proteins with a high isoelectric point). We
know that the C-terminal domain of RYBP becomes ordered
upon binding to C-RING1B (25), but from the NMR spectra of
NUPR1 (Fig. 4A), NUPR1 remained disordered. We have several
pieces of evidence to support this hypothesis. First, we did not
observe large changes in the steady-state far-UV CD spectra of
the complex and that obtained from the sum of the isolated
proteins. Second, we did not observe two transitions, or alterna-
tively a very broad one, in the far-UV CD thermal denaturations
(which could indicate the presence of two well-folded proteins that
are dissociating). Finally, we could argue that the flexibility of the
formed complex, where NUPR1 is not folded, was responsible for
the absence of thermogram in ITC (37). The persistently disor-
dered conformation of NUPR1 seems to be a general feature (33,
34, 38): Whatever molecule (synthetic, DNA, or protein) is bound
to it, it is not capable of altering its disordered nature. However,
binding to C-RING1B had an intermediate-to-slow exchange rate
within the NMR time scale (either for C-RING1B or NUPR1).
This time-scale regime was also kept in binding of C-RING1B to
RYBP (Fig. S4), and it could be a feature derived from the dis-
ordered nature of both proteins. This finding means that the small
variations in ellipticity at 222 nm observed in the far-UV CD upon
binding (Fig. 1B) did not involve formation of a rigid structure, or
at least not in NUPR1.
The interaction between the two proteins was also specific, as
shown by two pieces of evidence: (i) the results in cellulo of the
PLAs in NUPR1 knockout cells by CRISPR/Cas9n methods and
(ii) the results obtained with the Thr68Gln and Ala33Gln/
Thr68Gln variants of NUPR1 in vitro and in cellulo, whose mu-
tations at those two specific residues decreased the interaction
between NUPR1 and C-RING1B. These experimental results
seemed to be confirmed by the docking in silico of the complexes
of C-RING1B with NUPR1 mutants.
The monomeric CBX domains are also partially disordered in
the absence of C-RING1B (24), but they seem to fold upon
binding (25). The fact that the chemical shifts in the spectra of
C-RING1B were not altered upon addition of NUPR1 (Fig. 4)
species suggests that the basic scaffold of the protein remained
unaltered (as happens upon addition of RYBP; Fig. S4).
Structural Determinants of the C-RING1B/NUPR1 Interaction in NUPR1.
The recognition region of NUPR1 involved residues around the
30s, as suggested by the NMR results with the wild type and the
findings with the mutant species (Fig. 3), and further confirmed
by molecular dynamics (MD) simulations (Fig. 5 and Fig. S7).
The aromatic residues in this region also intervene in the binding
to prothymosin α (33); furthermore, previous MD simulations
suggest they also play a role in the binding to DNA (45) and in
the binding of drugs against NUPR1 (38). In fact, in this work,
we further show that one of those drugs (TFP) also hindered the
binding between C-RING1B and wild-type NUPR1. Thus, we
suggest that the same “hot-spot” region is used for binding any of
the natural NUPR1 partners (DNA, MSL1, prothymosin α, and
C-RING1B) and synthetic drugs.
The functional plasticity of NUPR1 is behind its high promiscuity;
in multipartite binding, IDPs use small linearly arranged sequences
of residues to mediate binding, the so-called short lineal motifs
(SLiMs). These SLiMs tend to range from 3 to 13 residues in length,
and therefore a single IDP can accommodate several SLiMs, which
facilitates multivalent interactions with other molecules (46). How-
ever, a single IDP can have multiple SLiMs capable of recognizing
distinct binding partners, acting as a scaffold for a high-order bio-
molecular complex formation (47). Our results suggest that NUPR1
has several SLiMs facilitating multivalent interactions, and these
SLiMs are critical to allow the binding toward its different bio-
molecular partners. In our previous studies we have also shown that
Thr68 is involved in the binding of NUPR1 to other macromolecules
(38). The region around Thr68, together with the polypeptide patch
around the 30s, is the most hydrophobic one on the Kyte–Doolitle
scale (Fig. S6). In this work, because NMR experiments were carried
out at pH 7.0 [where the hydrogen exchange with the solvent is faster
than at pH 4.5 (40)], most of the residues of NUPR1 were not
observed (because they are not hydrogen-bonded for long periods of
time or, alternatively, they are not buried within a well-folded,
compact structure). Thus, we did not have any experimental NMR
evidence that this other region of NUPR1 was involved in binding to
C-RING1B; however, the MD simulations suggest that Thr68 in-
tervened in binding to NUPR1 (Fig. 5), similarly to the 30s region,
and our mutagenesis studies also indicate that that amino acid in-
tervenes in binding. It is interesting to note that some SLiMs in
other IDPs have also been shown to function as high promiscuous
binders; for instance, the transactivation domain of p53 is known to
interact with multiple proteins by using the same binding motif
with structurally distinct binding modes upon engagement of its
several partners (48). Our results suggest that in NUPR1, Ala33, and
Thr68 are also promiscuous SLiMs.
The measured Kd of NUPR1 for C-RING1B is similar to that
observed for MSL1 (∼3 μM) (34), for prothymosin α (∼6 μM)
(33), and for different drugs capable of binding to NUPR1 and
competing with the binding between NUPR1 and MSL1 (38).
Such affinity is relatively small, but we believe that this low value
is necessary to obtain a proper regulation of the several pathways
where NUPR1 intervenes (32), achieving a high specificity de-
spite a low affinity. Affinities with a similar order of magnitude
(i.e., in the range 1–10 μM) have also been described in the
formation of “fuzzy” complexes, involving at least an IDP, which
remains disordered upon binding (49, 50).
Finally, although the observation of how a sole mutation of a
single residue in an IDP causing disruption of the interactions with
molecular partners could seem unusual, there are a few examples in
the literature. For instance, in the N-terminal membrane-binding
site of α-synuclein, two familial mutations (Ala30Pro and Glu46Lys)
have been hypothesized to alter membrane binding by changing the
population of its conformational ensemble (51, 52).
Structural Determinants of the C-RING1B/NUPR1 Interaction in
C-RING1B. The X-ray structures of C-RING1B with CBX [3GS2
(25)] and the C-terminal region of RYBP [3IXS (25)] show that
any of the latter proteins pack against the side chains of Val229,
Pro234, Tyr247, Ile248, Thr250, Ala254, His258, Leu259,
Tyr262, Val265, and Pro324, together with electrostatic inter-
actions involving Glu227, Arg247, Lys249, and Arg266 (25) of
C-RING1B. Many of these residues were observed to interact with
NUPR1 in our in silico models (discussed above). Interestingly
enough, from our fluorescence titration experiments (Fig. 1) the
sole tryptophan (Trp319), or its surroundings (such as Pro324),
of C-RING1B were also affected by NUPR1, although, probably,
the environment of some of the seven tyrosines was also affected
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by the presence of the IDP. As we observed in our MD simu-
lations, the sole Trp319 is close to cluster Cl-1, and then we had
direct evidence (fluorescence results) of the validity of the MD
findings. Therefore, as with NUPR1, the “hot-spot” region of
C-RING1B in the interaction with any molecular partner is
the same.
Although the binding regions identified for C-RING1B are fairly
exposed to the solvent, the two patches accessible to any residue of
NUPR1 (Cl-1 and Cl-2, Fig. 5) have a relatively large surface area,
whereas only Ala33 and Thr68 can dock into smaller and more
specific binding locations (Cl-3, Cl-4, and Cl-5). These two residues
are not very far away in the ensemble conformation obtained in our
MD simulations of the whole protein (38), and they can contribute
to hold nearby binding partners in a sort of “weak hydrophobic
clamp.” In such a mechanistic model these two residues would act
as gentle tongs ready to close when another hydrophobic region
(from a biomolecule or from a drug) is in the surroundings, as those
in Cl-3, Cl-4, and Cl-5. When one end of the tong (for instance,
Ala33) could be altered (by mutation), the binding could be se-
verely crippled, although interaction with the other end of the tong
(Thr68) would still be present and could be sufficient to maintain
the binding. We can conclude, based on the hydrophobicity plots
(Fig. S6) and our own mutagenesis studies, that hydrophobicity has
a central role for both proteins in determining their interactions;
however, additional and significant contributions include local
geometric features and other particular characteristics of the spe-
cific binding residues involved. Examples include the possibility of
hydrogen bonding for the side chain of Thr68 in NUPR1, or elec-
trostatic interactions for both proteins.
Conversely to what happens with NUPR1, the affinities of
C-RING1B for CBX or the C-terminal region of RYBP are much
larger [in the nanomolar range (25)]. This result implies that in the
simultaneous presence of the three proteins (C-RING1B, NUPR1,
and either CBX or RYBP), unless there is a kinetic effect C-RING1B
will first bind to CBX or RYBP, due to their larger affinity.
C-RING1B is a dimeric protein (its self-association constant is
∼200 μM) (17). Except for the NMR titration experiments, the
rest of the experiments were carried out under conditions where
the dominant C-RING1B species was the monomer. These
findings suggest that the “competent” species in binding to
NUPR1 is the C-RING1B monomer. The other biomolecules
known to interact with NUPR1 are either monomeric (prothy-
mosin α) (33) or oligomeric (MSL1) (34), but in the latter case
we do not know the exact self-association state of the protein.
The fact that the titration of 15N-labeled NUPR1 did not lead to
a reliable estimation of Kd, conversely to what we observed in the
titration of 15N-labeled C-RING1B (where the concentration
was held constant at 125 μM, corresponding to a 30% population
of dimer) with any of the NUPR1 species, further suggests
that the monomeric species of C-RING1B is the “competent”
one. A similar behavior, when involving self-associated species,
which is the titrating molecule in the titration experiment, has
been observed in fluorescence experiments of protein–DNA
interactions (53).
Possible Biological Implications. At this point, it is important to
stress that the discovery of this interaction in cellulo between
the two proteins was prompted by a comparison with the physico-
chemical properties of other already-known partners of C-RING1B
with the features of NUPR1. Thus, it should be interesting to
test whether similar hypothesis-driven studies can be carried
out with other partners of both proteins to identify possible
protein cascades.
In light of these findings, and on the basis of the known functions
of both proteins NUPR1 and C-RING1B, it becomes important to
speculate on the potential implications of their interactions for
cancer development. Members of the Polycomb complexes of
epigenomic regulators are well-characterized cell fate regulators,
through their ability to silence entire gene expression networks that
give rise to distinct phenotypes (6, 54). In addition, PRCs are im-
portant elements in stem-cell renewal and differentiation (54, 55).
These proteins are among the best-characterized “epigenomic
oncogenes,” playing significant roles in a large variety of solid tu-
mors, as well as lymphomas and leukemias. Therefore, due to their
ability to regulate gene expression processes that determine cellular
patterns of morphogenesis, Polycomb complexes are key regulators
of cell development, maintain tissue homeostasis, and, when al-
tered, give rise to cancer. NUPR1 plays a major role in pancreatic
ductal adenocarcinoma (PDAC), because the oncogenic KrasG12D
expression in the mouse pancreas is unable to promote pre-
cancerous lesions in the absence of NUPR1 expression (31, 32, 35).
In addition, RING1B is weakly expressed in pancreatic intra-
epithelial neoplasias but strongly expressed in PDAC [as well as
in hepatocellular carcinoma (14)]. Therefore, we speculate that
NUPR1 and C-RING1B might intervene in regulating some of the
pathways involved in chromatin-mediated processes, gene regu-
lation, and/or carcinogenesis, where the binding between both
proteins can be shifted by the presence of other proteins such as
RYBP and CBX (due to the higher value of their affinity con-
stants). Alternatively, it could be suggested that under conditions
of low expression of RYBP, NUPR1 could help in carrying out its
same functions. The expression of RYBP has been reported to
be reduced in lung, cervical, prostate, and liver cancers; in addi-
tion, RYBP has an apoptosis-inducing capacity, inhibiting cancer
growth, metastasis, and chemoresistence in vitro and in vivo (56).
Because NUPR1 in complex with prothymosin α can regulate the
cell’s apoptotic response (31, 33), we hypothesize that in the ab-
sence of RYBP (as in some types of cancer) the cell expresses larger
amounts of NUPR1 to compensate for that loss, taking over the
functions of RYBP in a sort of self-defense mechanism. In this
sense, it is interesting to note that in noncanonical complexes of
PRC1 other DNA-binding proteins are heterodimeric transcription
factors, such as the Myc-associated factor X (ref. 57 and references
therein). Therefore, in any of the possible scenarios NUPR1 could
be a modulator of the activity of PcG proteins by binding to
RING1B and controlling its binding to other macromolecules.
Our work provides structural and functional evidence describing
the interaction of NUPR1 with RING1B, through its C-terminal
region. Thus, it becomes relevant to discuss the potential roles of
this interaction. In this regard, we underscore the fact that
RING1B is a ubiquitin E3 ligase, whose catalytic activity is acti-
vated by interaction with other proteins. Noteworthy, however, it
has been previously shown that RING1B can also interact with
other DNA-binding proteins, which are not part of the PcG (57).
These interactions are thought to direct the E3 ligase activity on
other chromatin proteins that do not belong to the Pc complex.
Furthermore, RING1B not only self-ubiquitinates but also inter-
acts with other proteins, modulating their degradation (57, 58).
Thus, it seems that RING1B has both Pc-dependent and Pc-
independent functions by associating with other chromatin pro-
teins. Our data reveal that RING1B binds to another IDP chro-
matin protein, and they pave the way for future investigation as
to whether this complex plays a role in either Pc-dependent
or -independent processes.
Materials and Methods
Fluorescence. Fluorescence spectra were collected on a Cary Varian spectro-
fluorimeter (Agilent) interfaced with a Peltier, at 25 °C. Experiments were
carried out at pH 6.8 (20 mM phosphate buffer), where C-RING1B has a well-
folded conformation (17). The samples were prepared the day before and
left overnight at 5 °C. A 1-cm-pathlength quartz cell (Hellma) was used.
Steady-state spectra. Protein samples were excited at 280 and at 295 nm to
characterize a possible different behavior of tryptophan or tyrosine residues
in C-RING1B (59). There are only two tyrosine residues in NUPR1 and mu-
tants; C-RING1B has a single tryptophan and seven tyrosines. Sample con-
centration was 28 μM of C-RING1B (in protomer units) and 14 μM of wild-
type NUPR1. The slit widths were 5 nm for both the excitation and emission
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light. The experiments were recorded between 300 and 400 nm. The signal
was acquired for 1 s and the increment of wavelength was set to 1 nm. Blank
corrections were made in all spectra.
Binding experiments. Increasing amounts of wild-type NUPR1 or mutants, in
the range 0–20 μM, were added to a solution with a fixed concentration of
C-RING1B (5 μM of protomer). Under these conditions, C-RING1B is mainly in
its monomeric form [because its self-association constant is ∼200 μM (17)].
The experimental set was that described above. The titrations were repeated
three times. The fluorescence values of a blank solution containing only
wild-type NUPR1 or its mutants were subtracted for each point. The disso-
ciation constant of each complex, Kd, was calculated by fitting the plot of
the observed fluorescence change of C-RING1B versus added NUPR1 proteins
to the following equation (53, 60):
where Fmeas is the measured fluorescence at any particular concentration of
NUPR1 species after subtraction of the blank; ΔFmax is the difference in the
fluorescence of C-RING1B when all of NUPR1 species is forming the complex
with the fluorescence of isolated C-RING1B; F is the fluorescence intensity
when no NUPR1 species has been added; [C-RING1B]T is the constant, total
protein concentration of C-RING1B (5 μM in protomer units); and [NUPR1]T is
the total concentration of NUPR1 species, which is varied during the titra-
tion. The Kd was determined by following the fluorescence at 330 nm. Each
titration was repeated three times. At all used concentrations the absor-
bance of NUPR1 species was kept lower than 0.2 units of absorbance (at
280 nm) to avoid inner filter effects during fluorescence excitation (61).
CD. CD spectra were collected on a Jasco J810 or J815 spectropolarimeters
(Jasco) fitted with thermostated cell holders and interfaced with Peltiers. The
instruments were periodically calibrated with (+) 10-camphorsulphonic acid.
Far-UV steady-state spectra. Isothermal wavelength spectra of either the iso-
lated proteins or the complex of C-RING1B (31 μM protomer units) and wild-
type NUPR1 (at 20 μM) at pH 6.8 (20 mM phosphate buffer) were acquired at
a scan speed of 50 nm/min with a response time of 2 s and averaged over
four scans at 25 °C. For the experiments with the mutants the concentrations
of any of the two species were the same as for the assays with the wild-type
NUPR1. Measurements were performed in 0.1-cm-pathlength quartz cells.
All spectra were corrected by subtracting the baseline. The samples were
prepared the day before and left overnight at 5 °C.
Thermal denaturation experiments. Thermal denaturation experiments of iso-
lated C-RING1B (31 μM protomer units) and of the complex [formed by
31 μM (protomer units) of C-RING1B and 20 μM of NUPR1 species] were
performed at heating rates of 60 °C/h and a response time of 8 s at pH 6.8
(20 mM phosphate buffer). Thermal scans were collected at 222 nm from
25 to 80 °C in 0.1-cm-pathlength cells. The possibility of drifting of the CD
spectropolarimeter was tested by running two samples containing only
buffer, before and after the thermal experiments; no difference was ob-
served between the scans. It is important to note that isolated wild-type
NUPR1 does not show any sigmoidal transition because it is an IDP (30).
However, thermal denaturations of C-RING1B are irreversible (17); in fact,
precipitation of C-RING1B was always observed either in the presence or the
absence of any of the NUPR1 species.
NMR Spectroscopy. The NMR experiments were acquired on a Bruker Avance
DRX-500 spectrometer equipped with a triple resonance probe and z-pulse
field gradients. Experiments were acquired at 25 °C and pH 7.2 (Tris, 50 mM);
probe temperature was calibrated with a methanol NMR standard (62). The
peaks in the 2D 1H-15N HSQC NMR spectra (63) of NUPR1 were identified by
using previously determined assignments at pH 4.5 (34). Spectra were ac-
quired in echo–antiecho mode, with the carrier frequency at 8.00 ppm. For
experiments using 15N-labeled NUPR1, a [NUPR1] of 150 μM was used, and
increasing concentrations of unlabeled C-RING1B (64, 96, and 110 μM, in
protomer units) were added. At each step, the final volume of the resulting
sample was reduced to 500 μL by using Amicon centrifugal devices. For ex-
periments with 15N-labeled C-RING1B, a [C-RING1B] of 125 μM (in protomer
units) was used in all experiments, and increasing concentrations of un-
labeled wild-type NUPR1 (20, 40, 60, and 80 μM) were added. Similar con-
centrations were used for Thr68Gln, but higher ones were used for the
double mutant (Fig. S5). Spectra for the mutants were acquired in the TPPI
mode (62). The final volume of the resultant sample (after addition of the
corresponding titrating protein) was reduced to 500 μL by using Amicon
centrifugal devices at each step.
The spectra were typically acquired with 2 K complex points in the 1H di-
mension, 60 complex points in the 15N dimension, with 32 or 64 scans. Typical
spectral widths were 6,000 (1H) and 1,500 (15N) Hz. The resulting matrix of each
experiment was zero-filled to double the number of original points in all di-
mensions and shifted squared sine-bell apodization functions were applied, be-
fore Fourier transformation. NMR data were processed and analyzed using Topsin
1.3 (Bruker). Signal intensities in the NMR titration experiments weremeasured by
using the same program, and in each spectrum intensities were corrected by the
corresponding value of the receiver gain at each particular concentration of the
proteins that was being added during the titration. Spectra were calibrated with
external TSP for 1H and for the indirect dimensions as described (64).
PLA. HeLa cells were seeded in six-well plates on coverslips and transfected
with 2 μg of DNA (NUPR1-FLAG and RING1B-HA) RING1B-HA and the mu-
tants NUPR1-Ala33Gln-FLAG NUPR1-Thr68Gln-FLAG and NUPR1-Ala33Gln/
Thr68Gln-FLAG) and 6 μL of Lipofectamine 2000 Transfection Reagent
(Thermo Fisher Scientific) per well. Cells were assayed 24 h posttransfection.
Cells were washed twice in PBS, fixed, washed twice again, permeabilized in
PBS/0.1% Triton X-100, and saturated with blocking solution for 30 min
before immune-staining with Duolink by using PLA Technology (Sigma-
Aldrich) following the manufacturer’s protocol. Slides were processed for
in situ PLA by using sequentially the Duolink In Situ Detection Reagents Red,
Duolink In Situ PLA Probe Anti-Mouse MINUS, and Duolink In Situ PLA Probe
Anti-Rabbit PLUS. The following antibodies were used: mouse monoclonal
anti-HA (12CA5; Santa Cruz Biotechnology), mouse monoclonal antibody
anti-FLAG M2 (Sigma-Aldrich), rabbit monoclonal antibody anti HA (Cell
Signaling Technology), and rabbit anti-human NUPR1 antibody chemically
synthesized (Neosystem) following previously described methods (65). In
these experiments, red fluorescence corresponds to the PLA-positive signal,
and it indicates that the two molecules belong to the same protein complex.
Blue fluorescence corresponds to nuclei (so-called DAPI staining). To check
the specificity of the PLA signal, negative control experiments omitting one
of the primary antibodies and positive control with NUPR1 and MSL1 (MSL1-
V5 plasmid) interaction (34) were performed. Unspecific binding was opti-
mized by using the proper antibodies and optimizing the transfection times.
Protein overexpression was used to obtain a clearer and better signal.
Preparations were mounted using Prolong Gold antifade reagent (Invi-
trogen) and image acquisition was carried out on an LSM 510 META confocal
microscope (Zeiss) and on a Nikon Eclipse 90i fluorescence microscope. Sta-
tistical analysis was performed by using a Student’s t test and the mea-
surement was expressed as mean ± SD.
In Silico Methods.
Model of the C-RING1B structure. The structure was built by using as a starting
template the X-ray structure of unbound C-RING1B [3H8H (18)], which in-
cludes protein residues 224–330. Missing side-chain atoms in five solvent-
exposed Glu/Lys residues were built in silico by using VMD (66). The
N-terminal portion and two missing loops (residues 240–242 and 273–284)
were reconstructed through the I-TASSER prediction server (67), with the
rest of the protein as a guiding template.
The complete structure was refined through MD simulations, to obtain a
representative ensemble. The protein was equilibrated first in a short NVT run
(10 ps) performed in the presence of restraints on the positions of nonhydrogen
atoms determined in crystallography, and then in a constraint-free run carried
out for 1 ns at room temperature andpressure. The simulation packageGROMACS
(68) was used with the AMBER ff99SB force field (69). Other simulation conditions
Fmeas =F +
ΔFmax
2½C-RING1BT
½C-RING1BT +½NUPR1T +Kd−ð½C-RING1BT +½NUPR1T +Kd2− 4½C-RING1BT½NUPR1T1=2 ;
#"
[1]
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that included thermostat and barostat reference values and coupling times,
treatment of electrostatics and van der Waals interactions, use of restraints
and time step in the integration of the equations of motions, and treatment
of periodic boundary conditions were as described (70, 71).
Molecular docking. The binding affinity of NUPR1 (wild-type or mutated species)
and C-RING1B was evaluated by performing a systematic molecular docking.
Portions of the NUPR1 sequence containing seven, five, or three consecutive
protein residues were considered. The rest of the backbone was truncated and
(when necessary) each fragment was capped with an acetyl or amide group at
the N or C terminus, respectively. We used this procedure, instead of consid-
ering the entire polypeptide chain, to reduce the exceedingly large number of
possible degrees of freedom in the calculation. This allows for an efficient
sampling of all local regions of NUPR1 bound to C-RING1B, whereas the rest of
the protein is assumed to interact mainly with the solvent.
The graphical interface AutoDock Tools 1.5.6 (72) was used to delete
apolar hydrogen atoms and select permissible dihedral angle torsions for the
fragments; molecular docking was performed by using AutoDock Vina (73). The
docking search included the whole surface of C-RING1B, and it was performed
with high exhaustiveness: The number of internal independent runs, and con-
sequently the simulation time, was higher than the default value by a factor 12.5
(a linear increase of the simulation time corresponds to an exponential increase
in the probability of finding proper energetic minima). For each simulation,
the best 20 docking conformations were obtained. This number was reduced
by eliminating the binding modes with a difference in the affinity score
<0.5 kcal/mol with respect to the most favorable conformation.
Data Availability. All of the materials (plasmid constructs) and data are
available from the authors upon request.
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